THTX submits Form 25; Nasdaq and issuer state compliance

Rhea-AI Filing Summary

Theratechnologies Inc. submitted a Form 25 notice (Commission File No. 001-35203) indicating removal of its class of securities from listing and/or registration on the Nasdaq Stock Market LLC. The filing states the Exchange has complied with the rules for striking the securities and that the issuer has complied with voluntary withdrawal requirements. Contact and address details for the issuer are provided.

Positive

• Exchange certified compliance with rules to strike the securities from listing
• Issuer complied with Nasdaq requirements for voluntary withdrawal

Negative

• Removal from Nasdaq listing may materially reduce liquidity and visibility for the securities
• Form 25 filed signals that shares will no longer trade on Nasdaq once the delisting is effective

Insights

Exchange Listings Specialist

Form 25 notifies removal of listing; exchange and issuer state procedural compliance.

The filing documents a formal notification to delist the class of securities for Theratechnologies from the Nasdaq Stock Market LLC using Form 25. It records that the Exchange believes it met rule requirements and that the issuer complied with voluntary withdrawal procedures.

Near term, this change affects trading venue and likely liquidity; monitor official exchange notices for the effective delisting date and any separate investor communications for details on transfer or quoting arrangements.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-35203

Issuer:	Theratechnologies Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	1100 - 2015 Peel street, 11th Floor
	Montreal	QUEBEC, CANADA	H3A1T8
Telephone number:					4,383,156,608

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Shares

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-09-25	By	Jennifer Fainer		CDO Analyst
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Theratechnologies (THTX) file with the SEC?

The company filed a Form 25 (Commission File No. 001-35203) notifying removal of a class of securities from listing and/or registration on the Nasdaq Stock Market LLC.

Does the filing say whether the Exchange complied with rules?

Yes. The filing states the Exchange has complied with its rules under 17 CFR 240.12d2-2(b) to strike the class of securities from listing and/or withdraw registration.

Did the issuer follow Nasdaq requirements for voluntary withdrawal?

Yes. The filing states the issuer has complied with the Exchange's rules and the requirements of 17 CFR 240.12d-2(c) for voluntary withdrawal.

What contact information is listed for Theratechnologies?

The filing lists the issuer's address as 1100 - 2015 Peel Street, 11th Floor, Montreal, Quebec and a telephone number as provided in the document.

Is an effective delisting date provided in the Form 25?

No effective delisting date is stated in the provided content; the filing only certifies rule compliance and voluntary withdrawal adherence.